These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38084917)

  • 41. A shuttle vector series for precise genetic engineering of Saccharomyces cerevisiae.
    Gnügge R; Liphardt T; Rudolf F
    Yeast; 2016 Mar; 33(3):83-98. PubMed ID: 26647923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Affibody Scaffolds Improve Sesquiterpene Production in Saccharomyces cerevisiae.
    Tippmann S; Anfelt J; David F; Rand JM; Siewers V; Uhlén M; Nielsen J; Hudson EP
    ACS Synth Biol; 2017 Jan; 6(1):19-28. PubMed ID: 27560952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic engineering Saccharomyces cerevisiae for de novo production of the sesquiterpenoid (+)-nootkatone.
    Meng X; Liu H; Xu W; Zhang W; Wang Z; Liu W
    Microb Cell Fact; 2020 Feb; 19(1):21. PubMed ID: 32013959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a panARS-based episomal vector in the methylotrophic yeast Pichia pastoris for recombinant protein production and synthetic biology applications.
    Camattari A; Goh A; Yip LY; Tan AH; Ng SW; Tran A; Liu G; Liachko I; Dunham MJ; Rancati G
    Microb Cell Fact; 2016 Aug; 15(1):139. PubMed ID: 27515025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Saccharomyces cerevisiae Shuttle vectors.
    Gnügge R; Rudolf F
    Yeast; 2017 May; 34(5):205-221. PubMed ID: 28072905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of the sesquiterpene (+)-valencene by metabolically engineered Corynebacterium glutamicum.
    Frohwitter J; Heider SA; Peters-Wendisch P; Beekwilder J; Wendisch VF
    J Biotechnol; 2014 Dec; 191():205-13. PubMed ID: 24910970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene Amplification on Demand Accelerates Cellobiose Utilization in Engineered Saccharomyces cerevisiae.
    Oh EJ; Skerker JM; Kim SR; Wei N; Turner TL; Maurer MJ; Arkin AP; Jin YS
    Appl Environ Microbiol; 2016 Jun; 82(12):3631-3639. PubMed ID: 27084006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic Engineering and Adaptive Evolution for Efficient Production of l-Lactic Acid in Saccharomyces cerevisiae.
    Zhu P; Luo R; Li Y; Chen X
    Microbiol Spectr; 2022 Dec; 10(6):e0227722. PubMed ID: 36354322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CrEdit: CRISPR mediated multi-loci gene integration in Saccharomyces cerevisiae.
    Ronda C; Maury J; Jakočiunas T; Jacobsen SA; Germann SM; Harrison SJ; Borodina I; Keasling JD; Jensen MK; Nielsen AT
    Microb Cell Fact; 2015 Jul; 14():97. PubMed ID: 26148499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic engineering of Saccharomyces cerevisiae for production of germacrene A, a precursor of beta-elemene.
    Hu Y; Zhou YJ; Bao J; Huang L; Nielsen J; Krivoruchko A
    J Ind Microbiol Biotechnol; 2017 Jul; 44(7):1065-1072. PubMed ID: 28547322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The yeast platform engineered for synthetic gRNA-landing pads enables multiple gene integrations by a single gRNA/Cas9 system.
    Baek S; Utomo JC; Lee JY; Dalal K; Yoon YJ; Ro DK
    Metab Eng; 2021 Mar; 64():111-121. PubMed ID: 33549837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined metabolic engineering of precursor and co-factor supply to increase α-santalene production by Saccharomyces cerevisiae.
    Scalcinati G; Partow S; Siewers V; Schalk M; Daviet L; Nielsen J
    Microb Cell Fact; 2012 Aug; 11():117. PubMed ID: 22938570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic engineering of Saccharomyces cerevisiae for enhanced production of caffeic acid.
    Zhou P; Yue C; Shen B; Du Y; Xu N; Ye L
    Appl Microbiol Biotechnol; 2021 Aug; 105(14-15):5809-5819. PubMed ID: 34283270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production and quantification of sesquiterpenes in Saccharomyces cerevisiae, including extraction, detection and quantification of terpene products and key related metabolites.
    Rodriguez S; Kirby J; Denby CM; Keasling JD
    Nat Protoc; 2014 Aug; 9(8):1980-96. PubMed ID: 25058645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites.
    Rahmat E; Kang Y
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4659-4674. PubMed ID: 32270249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Development of genetically stable recombinant Saccharomyces cerevisiae strains using combinational chromosomal integration].
    Zuo Q; Zhao X; Liu H; Hu S; Ma Z; Bai F
    Sheng Wu Gong Cheng Xue Bao; 2014 Apr; 30(4):669-73. PubMed ID: 25195256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Plasmid Design and Type of Integration Event on Recombinant Protein Expression in Pichia pastoris.
    Vogl T; Gebbie L; Palfreyman RW; Speight R
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330186
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression of recombinant multi-protein complexes in Saccharomyces cerevisiae.
    Mayle R; O'Donnell M
    Methods Enzymol; 2021; 660():3-20. PubMed ID: 34742395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Increase of copy number of HMG-CoA reductase and FPP synthase genes improves the amorpha4,11-diene production in engineered yeast].
    Kong JQ; Cheng KD; Wang LN; Zheng XD; Dai JG; Zhu P; Wang W
    Yao Xue Xue Bao; 2007 Dec; 42(12):1314-9. PubMed ID: 18338647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction and Optimization of Nonclassical Isoprenoid Biosynthetic Pathways in Yeast Peroxisomes for (+)-Valencene Production.
    Cao C; Zhang H; Cao X; Kong S; Zhu B; Lin X; Zhou YJ
    J Agric Food Chem; 2023 Jul; 71(29):11124-11130. PubMed ID: 37437260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.